Mucormycosis after scorpion sting: Case report

Mycoses

Volumn 56, Issue 5, 2013, Pages 589-591

  Pourahmad, Morteza ^a   Sepidkar, Abdolali ^a   Farokhnia, Mohmmad H ^a   Tadayon, Seyed M K ^a   Salehi, Hassan ^b   Zabetian, Hassan ^a  

^a JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Immunocompromised patients; Immunological competence; Mucormycosis; Scorpion; Sting

Indexed keywords

AMPHOTERICIN B; CEPHALOSPORIN; CLINDAMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CELLULITIS; FEMALE; GRAM STAINING; HUMAN; IMMUNOCOMPROMISED PATIENT; INSECT STING; MUCORMYCOSIS; PRIORITY JOURNAL; SCORPION;

IMMUNOCOMPROMISED PATIENTS; IMMUNOLOGICAL COMPETENCE; MUCORMYCOSIS; SCORPION; STING;

DERMATOMYCOSES; FEMALE; HUMANS; MIDDLE AGED; MUCOR; MUCORMYCOSIS; SCORPION STINGS; SKIN;

FUNGI; MUCOR; SCORPIONES;

EID: 84881030815     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12066     Document Type: Article

References (17)

1. Reddy IS, Rao NR, Shankar RV, Rao R. Primary cutaneous mucormycosis (zygomycosis) caused by Apophysomyces elegans. Indian J Dermatol Venereol Leprol 2008; 74: 367-70.
2. Tapia EO, Chahin AC, Concha FC. Primaary cutaneous mucormycosis: two case reports and review of the literature. Rev chilena infectol 2011; 28: 269-73.
3. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012; 54: 523-34.
4. Linerberry KD, Boettcher AK, Blount AL, Burgess SD. Cutaneous mucormycosis of the upper extremity in an immunocompetent host: case report. J Hand Surg Am 2012; 37: 787-91.
5. Hadaschik E, Koschny R, Willinger B, Hallscheidt P, Enk A, Hartschuh W. Pulmonary, rhino-orbital and cutaneous mucormycosis caused by Rhizomucor pusillus in an immunocompromised patient. Clin Exp Dermatol 2012; 37: 355-7.
6. Mignogna MD, Fortuna G, Leuci S et al. Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis 2011; 15: 533-40.
7. Roden M, Zaouis T, Buchanan W et al. Epidemiology and outcome of zygomycosis: a report of 929 reported cases. Clin Infect Dis 2005; 41: 634-53.
8. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis; Pathophysiology, presentation and management. Clin Microbiol Rev 2005; 18: 556-69.
9. Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect 2009; 15: 41-5.
10. Al-Asiri RH, Van Dijken PJ, Mahmood MA, Al-Shahed MS, Rossi ML, Osoba AO. Isolated hepatic mucormycosis in an immunocompetent child. Am J Gastroenterol 1996; 91: 606-7.
11. Butala A, Shah B, Cho YT, Schmidt MF. Isolated pulmonary mucormycosis in an apparently normal host: a case report. J Natl Med Assoc 1995; 87: 572-4.
12. Lechevalier P, Hermoso DG, Carol A et al. Molecular Diagnosis of Saksenaea vasiformis Cutaneous Infection after Scorpion Sting in an Immunocompetent Adolescent. J Clin Microbiol 2008; 46: 3169-72.
13. Andresen D, Donaldson LA, Choo AK et al. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 2005; 365: 876-8.
14. Adam RD, Hunter G, Ditomasso J, Comerci G. Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994; 19: 67-76.
15. Cloughley R, Kelehan J, Corbett-Feeney G et al. Soft tissue infection with Absidia corymbifera in a patient with idiopathic aplastic anemia. J Clin Microbiol 2002; 40: 725-27.
16. Holland J. Emerging zygomycoses of humans: Saksenaea vasiformis and Apophysomyces elegans. Curr Top Med Mycol 1997; 8: 27-34.
17. Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol 1994; 32: 1823-24.